Journal of Clinical Endocrinology & Metabolism, Vol 57, 904-910, Copyright © 1983 by Endocrine Society

ARTICLES

Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance

S Del Prato, R Nosadini, A Tiengo, P Tessari, A Avogaro, R Trevisan, A Valerio, M Muggeo, C Cobelli and G Toffolo

To clarify whether type I diabetes is characterized by insulin resistance, insulin-mediated glucose metabolism (M; milligrams per kg/min) was estimated by means of the glucose clamp technique in five insulin-dependent diabetic patients and six normal subjects. Three glucose clamps were carried out under different metabolic conditions. Free insulin plateaux were similar during each clamp in both groups. The first clamp was performed in normal subjects after an overnight fast [blood glucose, 80 +/- 3 mg/dl (mean +/- SEM)] and in diabetic patients 18 h after insulin withdrawal (blood glucose, 366 +/- 47 mg/dl). Diabetic patients had a M value (4.25 +/- 0.74) not different from normals (5.38 +/- 0.63; P = NS). The second clamp was done with the same glycemic values (approximately 125 mg/dl) in both groups. M increased to 8.07 +/- 1.06 (P less than 0.01) in the normal subjects and decreased to 2.87 +/- 0.50 (P = NS) in the diabetic patients. The M value in the diabetic patients was lower than that in the normal subjects (P less than 0.05). The third clamp was performed in three diabetic patients after 1 month of treatment with continuous sc insulin infusion. The mean blood glucose level was 88 +/- 6 mg/dl, and M was 3.23 +/- 0.38, significantly lower than that of the normal subjects in the basal state (P less than 0.05). No differences were found in insulin binding to erythrocytes. The mean plasma clearance rate (milliliters per m2/min) of free insulin was the same in both groups (428 +/- 113 in normal subjects and 354 +/- 83 in diabetic patients). Basal endogenous glucose production was higher in the diabetics (3.13 +/- 0.48 mg/kg X min) than in the normal subjects (1.71 +/- 0.57). During the clamp, however, endogenous glucose production was similarly inhibited (approximately 95%) in both groups. Multiple glucose clamp studies were also performed at three different insulin infusion rates (21, 73, and 760 mU/m2 X min, respectively) to generate an insulin-dose response curve for glucose disposal in six diabetic patients treated with continuous sc insulin infusion for at least 6 months. This allowed investigation of the effect of chronic strict insulin therapy leading to normal glucose and intermediary metabolite levels and identification of the cellular mechanism of insulin resistance. A significant reduction of the maximal glucose disposal rate (10.7 +/- 0.5 mg/kg X min) was found in these diabetic patients compared to that in normal subjects (14.9 +/- 1.0; P less than 0.05).(ABSTRACT TRUNCATED AT 400 WORDS)

This article has been cited by other articles:

				L. Puricelli, E. Iori, R. Millioni, G. Arrigoni, P. James, M. Vedovato, and P. Tessari Proteome Analysis of Cultured Fibroblasts from Type 1 Diabetic Patients and Normal Subjects J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3507 - 3514. [Abstract] [Full Text] [PDF]

				S. M. Strowig and P. Raskin The Effect of Rosiglitazone on Overweight Subjects With Type 1 Diabetes Diabetes Care, July 1, 2005; 28(7): 1562 - 1567. [Abstract] [Full Text] [PDF]

				G. Perseghin, G. Lattuada, M. Danna, L. P. Sereni, P. Maffi, F. De Cobelli, A. Battezzati, A. Secchi, A. Del Maschio, and L. Luzi Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes Am J Physiol Endocrinol Metab, December 1, 2003; 285(6): E1174 - E1181. [Abstract] [Full Text] [PDF]

				J. R. Greenfield, K. Samaras, and D. J. Chisholm Insulin Resistance, Intra-Abdominal Fat, Cardiovascular Risk Factors, and Androgens in Healthy Young Women with Type 1 Diabetes Mellitus J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1036 - 1040. [Abstract] [Full Text] [PDF]

				R. Bergholm, J. Westerbacka, S. Vehkavaara, A. Seppälä-Lindroos, T. Goto, and H. Yki-Järvinen Insulin Sensitivity Regulates Autonomic Control of Heart Rate Variation Independent of Body Weight in Normal Subjects J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1403 - 1409. [Abstract] [Full Text]